Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01043653 · ClinicalTrials.gov registry record

Assessing Mental Illness Recovery

A clinical trial of Serious Mental Illness, sponsored by VA Office of Research and Development.

Completed
Registry status
250
Enrollment target
3
Study locations

NCT01043653: Completed study of Serious Mental Illness, sponsored by VA Office of Research and Development.

NCT01043653 is a study of Serious Mental Illness that has completed, run by VA Office of Research and Development. The registered enrollment target is 250 participants, above the 105-participant average among 7 other Serious Mental Illness trials with a reported enrollment target (138% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01043653, a study of Serious Mental Illness, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
250 participants
Enrollment target
3
Study locations

Study Summary

In 2003 the VA Undersecretary's Action Agenda mandated that mental health services throughout the system be transformed to a recovery model. That mandate and many of the Workgroup recommendations have since been formalized in the Uniform Mental Health Services Package, which specifies a range of recovery-oriented services that must be available to veterans. A key aspect of these policy mandates is the need to assess recovery status of veterans and to monitor their progress over time as a way to evaluate the effectiveness of recovery services. However, there is no established instrument that is suitable for system-wide application. The purpose of this project is to develop a reliable, valid and practical measure of recovery, and use the measure in a study to better understand recovery in individuals with serious mental illness.

Primary Outcome

The PANSS is a clinician-rated measure of the presence and severity of symptoms of psychosis. A total score was calculated by averaging the responses on the items (range=1 to 7) scores, with higher scores indicating greater severity of psychiatric symptoms.

Conditions Studied

Study Locations (3)

Maryland

  • University of Maryland, Division of Psychiatry - Baltimore
  • VA Maryland Health Care System, Baltimore - Baltimore

District of Columbia

  • Washington DC VA Medical Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2010-01
Est. Completion 2013-09
VA Office of Research and Development

1,668 total trials

What the finished NCT01043653 record still lists

NCT01043653 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 105-participant average among 7 other Serious Mental Illness trials with a reported enrollment target (138% higher).

The record links to 1 condition, with Serious Mental Illness appearing as the primary indexed condition, and to 0 interventions.

NCT01043653 reports a single indexed study location in Maryland, District of Columbia.

Frequently Asked Questions

What is clinical trial NCT01043653 about?

NCT01043653 is a clinical study titled "Assessing Mental Illness Recovery". In 2003 the VA Undersecretary's Action Agenda mandated that mental health services throughout the system be transformed to a recovery model. That mandate and many of the Workgroup recommendations have since been formalized in the Uniform Mental Health Services Package, which specifies a range of rec...

What is the current status of trial NCT01043653?

This trial is currently completed. The enrollment target is 250 participants. The study started on 2010-01. Estimated completion is 2013-09.

What conditions does trial NCT01043653 study?

This clinical trial studies the following conditions: Serious Mental Illness.

Who is sponsoring clinical trial NCT01043653?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01043653 being conducted?

This trial has 3 study locations across District of Columbia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Serious Mental Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01043653, the US trial registry maintained by the National Library of Medicine. NCT01043653 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.